Article
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Circulation - 8 May 2007
Oumouna-Benachour Karine, Hans Chetan P, Suzuki Yasuhiro, Naura Amarjit, Datta Rahul, Belmadani Souad, Fallon Kenneth, Woods Cooper, Boulares A Hamid
Abstract excerpt
BACKGROUND: Poly(ADP-ribose) polymerase (PARP) was suggested to play a role in endothelial dysfunction that is associated with a number of cardiovascular diseases. We hypothesized that PARP may play an important role in atherogenesis and that its inhibition may attenuate atherosclerotic plaque development in an experimental model of atherosclerosis. METHODS AND RESULTS: Using a mouse (apolipoprotein E...
Topics
- Active Transport, Cell Nucleus
- Animals
- Aortic Diseases
- Apolipoproteins E
- Apoptosis
- Atherosclerosis
- Cells, Cultured
- Chemokine CCL2
- Cholesterol
